世界のイソプレナリン（イソプロテレノール）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Isoprenaline (Isoproterenol) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5811 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、イソプレナリン（イソプロテレノール）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（注射、錠剤、その他）、用途別市場規模（徐脈、喘息、心臓ブロック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・イソプレナリン（イソプロテレノール）の市場動向 ・企業の競争状況、市場シェア ・イソプレナリン（イソプロテレノール）の種類別市場規模と予測2016-2027（注射、錠剤、その他） ・イソプレナリン（イソプロテレノール）の用途別市場規模と予測2016-2027（徐脈、喘息、心臓ブロック、その他） ・イソプレナリン（イソプロテレノール）の北米市場規模2016-2027（アメリカ、カナダ） ・イソプレナリン（イソプロテレノール）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・イソプレナリン（イソプロテレノール）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・イソプレナリン（イソプロテレノール）の中南米市場規模2016-2027（メキシコ、ブラジル） ・イソプレナリン（イソプロテレノール）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sanofi Aventis、HOSPIRA、NEXUS PHARMAACEUTICALS、Amneal Pharmaceuticals, Inc、LGM Pharma、Cipla、Recipharm AB、Triveni Interchem、AMPHASTAR PHARMACEUTICALS、Biophore） ・結論

Isoprenaline (C11H17NO3) is an isopropyl analog of epinephrine. It is primarily used to treat asthma, heart block, and various lung related diseases.

Market Analysis and Insights: Global Isoprenaline (Isoproterenol) Market
The global Isoprenaline (Isoproterenol) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Isoprenaline (Isoproterenol) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Isoprenaline (Isoproterenol) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Isoprenaline (Isoproterenol) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Isoprenaline (Isoproterenol) market.

Global Isoprenaline (Isoproterenol) Scope and Market Size
Isoprenaline (Isoproterenol) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Isoprenaline (Isoproterenol) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Injection
Tablets
Others

Segment by Application
Bradycardia
Asthma
Heart Block
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi Aventis
HOSPIRA
NEXUS PHARMAACEUTICALS
Amneal Pharmaceuticals, Inc
LGM Pharma
Cipla
Recipharm AB
Triveni Interchem
AMPHASTAR PHARMACEUTICALS
Biophore

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Isoprenaline (Isoproterenol) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injection
1.2.3 Tablets
1.2.4 Others
1.3 Market by Application
1.3.1 Global Isoprenaline (Isoproterenol) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Bradycardia
1.3.3 Asthma
1.3.4 Heart Block
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Isoprenaline (Isoproterenol) Market Perspective (2016-2027)
2.2 Isoprenaline (Isoproterenol) Growth Trends by Regions
2.2.1 Isoprenaline (Isoproterenol) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Isoprenaline (Isoproterenol) Historic Market Share by Regions (2016-2021)
2.2.3 Isoprenaline (Isoproterenol) Forecasted Market Size by Regions (2022-2027)
2.3 Isoprenaline (Isoproterenol) Industry Dynamic
2.3.1 Isoprenaline (Isoproterenol) Market Trends
2.3.2 Isoprenaline (Isoproterenol) Market Drivers
2.3.3 Isoprenaline (Isoproterenol) Market Challenges
2.3.4 Isoprenaline (Isoproterenol) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Isoprenaline (Isoproterenol) Players by Revenue
3.1.1 Global Top Isoprenaline (Isoproterenol) Players by Revenue (2016-2021)
3.1.2 Global Isoprenaline (Isoproterenol) Revenue Market Share by Players (2016-2021)
3.2 Global Isoprenaline (Isoproterenol) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Isoprenaline (Isoproterenol) Revenue
3.4 Global Isoprenaline (Isoproterenol) Market Concentration Ratio
3.4.1 Global Isoprenaline (Isoproterenol) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Isoprenaline (Isoproterenol) Revenue in 2020
3.5 Isoprenaline (Isoproterenol) Key Players Head office and Area Served
3.6 Key Players Isoprenaline (Isoproterenol) Product Solution and Service
3.7 Date of Enter into Isoprenaline (Isoproterenol) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Isoprenaline (Isoproterenol) Breakdown Data by Type
4.1 Global Isoprenaline (Isoproterenol) Historic Market Size by Type (2016-2021)
4.2 Global Isoprenaline (Isoproterenol) Forecasted Market Size by Type (2022-2027)

5 Isoprenaline (Isoproterenol) Breakdown Data by Application
5.1 Global Isoprenaline (Isoproterenol) Historic Market Size by Application (2016-2021)
5.2 Global Isoprenaline (Isoproterenol) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Isoprenaline (Isoproterenol) Market Size (2016-2027)
6.2 North America Isoprenaline (Isoproterenol) Market Size by Type
6.2.1 North America Isoprenaline (Isoproterenol) Market Size by Type (2016-2021)
6.2.2 North America Isoprenaline (Isoproterenol) Market Size by Type (2022-2027)
6.2.3 North America Isoprenaline (Isoproterenol) Market Size by Type (2016-2027)
6.3 North America Isoprenaline (Isoproterenol) Market Size by Application
6.3.1 North America Isoprenaline (Isoproterenol) Market Size by Application (2016-2021)
6.3.2 North America Isoprenaline (Isoproterenol) Market Size by Application (2022-2027)
6.3.3 North America Isoprenaline (Isoproterenol) Market Size by Application (2016-2027)
6.4 North America Isoprenaline (Isoproterenol) Market Size by Country
6.4.1 North America Isoprenaline (Isoproterenol) Market Size by Country (2016-2021)
6.4.2 North America Isoprenaline (Isoproterenol) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Isoprenaline (Isoproterenol) Market Size (2016-2027)
7.2 Europe Isoprenaline (Isoproterenol) Market Size by Type
7.2.1 Europe Isoprenaline (Isoproterenol) Market Size by Type (2016-2021)
7.2.2 Europe Isoprenaline (Isoproterenol) Market Size by Type (2022-2027)
7.2.3 Europe Isoprenaline (Isoproterenol) Market Size by Type (2016-2027)
7.3 Europe Isoprenaline (Isoproterenol) Market Size by Application
7.3.1 Europe Isoprenaline (Isoproterenol) Market Size by Application (2016-2021)
7.3.2 Europe Isoprenaline (Isoproterenol) Market Size by Application (2022-2027)
7.3.3 Europe Isoprenaline (Isoproterenol) Market Size by Application (2016-2027)
7.4 Europe Isoprenaline (Isoproterenol) Market Size by Country
7.4.1 Europe Isoprenaline (Isoproterenol) Market Size by Country (2016-2021)
7.4.2 Europe Isoprenaline (Isoproterenol) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Isoprenaline (Isoproterenol) Market Size (2016-2027)
8.2 Asia-Pacific Isoprenaline (Isoproterenol) Market Size by Type
8.2.1 Asia-Pacific Isoprenaline (Isoproterenol) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Isoprenaline (Isoproterenol) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Isoprenaline (Isoproterenol) Market Size by Type (2016-2027)
8.3 Asia-Pacific Isoprenaline (Isoproterenol) Market Size by Application
8.3.1 Asia-Pacific Isoprenaline (Isoproterenol) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Isoprenaline (Isoproterenol) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Isoprenaline (Isoproterenol) Market Size by Application (2016-2027)
8.4 Asia-Pacific Isoprenaline (Isoproterenol) Market Size by Region
8.4.1 Asia-Pacific Isoprenaline (Isoproterenol) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Isoprenaline (Isoproterenol) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Isoprenaline (Isoproterenol) Market Size (2016-2027)
9.2 Latin America Isoprenaline (Isoproterenol) Market Size by Type
9.2.1 Latin America Isoprenaline (Isoproterenol) Market Size by Type (2016-2021)
9.2.2 Latin America Isoprenaline (Isoproterenol) Market Size by Type (2022-2027)
9.2.3 Latin America Isoprenaline (Isoproterenol) Market Size by Type (2016-2027)
9.3 Latin America Isoprenaline (Isoproterenol) Market Size by Application
9.3.1 Latin America Isoprenaline (Isoproterenol) Market Size by Application (2016-2021)
9.3.2 Latin America Isoprenaline (Isoproterenol) Market Size by Application (2022-2027)
9.3.3 Latin America Isoprenaline (Isoproterenol) Market Size by Application (2016-2027)
9.4 Latin America Isoprenaline (Isoproterenol) Market Size by Country
9.4.1 Latin America Isoprenaline (Isoproterenol) Market Size by Country (2016-2021)
9.4.2 Latin America Isoprenaline (Isoproterenol) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Isoprenaline (Isoproterenol) Market Size (2016-2027)
10.2 Middle East & Africa Isoprenaline (Isoproterenol) Market Size by Type
10.2.1 Middle East & Africa Isoprenaline (Isoproterenol) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Isoprenaline (Isoproterenol) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Isoprenaline (Isoproterenol) Market Size by Type (2016-2027)
10.3 Middle East & Africa Isoprenaline (Isoproterenol) Market Size by Application
10.3.1 Middle East & Africa Isoprenaline (Isoproterenol) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Isoprenaline (Isoproterenol) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Isoprenaline (Isoproterenol) Market Size by Application (2016-2027)
10.4 Middle East & Africa Isoprenaline (Isoproterenol) Market Size by Country
10.4.1 Middle East & Africa Isoprenaline (Isoproterenol) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Isoprenaline (Isoproterenol) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sanofi Aventis
11.1.1 Sanofi Aventis Company Details
11.1.2 Sanofi Aventis Business Overview
11.1.3 Sanofi Aventis Isoprenaline (Isoproterenol) Introduction
11.1.4 Sanofi Aventis Revenue in Isoprenaline (Isoproterenol) Business (2016-2021)
11.1.5 Sanofi Aventis Recent Development
11.2 HOSPIRA
11.2.1 HOSPIRA Company Details
11.2.2 HOSPIRA Business Overview
11.2.3 HOSPIRA Isoprenaline (Isoproterenol) Introduction
11.2.4 HOSPIRA Revenue in Isoprenaline (Isoproterenol) Business (2016-2021)
11.2.5 HOSPIRA Recent Development
11.3 NEXUS PHARMAACEUTICALS
11.3.1 NEXUS PHARMAACEUTICALS Company Details
11.3.2 NEXUS PHARMAACEUTICALS Business Overview
11.3.3 NEXUS PHARMAACEUTICALS Isoprenaline (Isoproterenol) Introduction
11.3.4 NEXUS PHARMAACEUTICALS Revenue in Isoprenaline (Isoproterenol) Business (2016-2021)
11.3.5 NEXUS PHARMAACEUTICALS Recent Development
11.4 Amneal Pharmaceuticals, Inc
11.4.1 Amneal Pharmaceuticals, Inc Company Details
11.4.2 Amneal Pharmaceuticals, Inc Business Overview
11.4.3 Amneal Pharmaceuticals, Inc Isoprenaline (Isoproterenol) Introduction
11.4.4 Amneal Pharmaceuticals, Inc Revenue in Isoprenaline (Isoproterenol) Business (2016-2021)
11.4.5 Amneal Pharmaceuticals, Inc Recent Development
11.5 LGM Pharma
11.5.1 LGM Pharma Company Details
11.5.2 LGM Pharma Business Overview
11.5.3 LGM Pharma Isoprenaline (Isoproterenol) Introduction
11.5.4 LGM Pharma Revenue in Isoprenaline (Isoproterenol) Business (2016-2021)
11.5.5 LGM Pharma Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Isoprenaline (Isoproterenol) Introduction
11.6.4 Cipla Revenue in Isoprenaline (Isoproterenol) Business (2016-2021)
11.6.5 Cipla Recent Development
11.7 Recipharm AB
11.7.1 Recipharm AB Company Details
11.7.2 Recipharm AB Business Overview
11.7.3 Recipharm AB Isoprenaline (Isoproterenol) Introduction
11.7.4 Recipharm AB Revenue in Isoprenaline (Isoproterenol) Business (2016-2021)
11.7.5 Recipharm AB Recent Development
11.8 Triveni Interchem
11.8.1 Triveni Interchem Company Details
11.8.2 Triveni Interchem Business Overview
11.8.3 Triveni Interchem Isoprenaline (Isoproterenol) Introduction
11.8.4 Triveni Interchem Revenue in Isoprenaline (Isoproterenol) Business (2016-2021)
11.8.5 Triveni Interchem Recent Development
11.9 AMPHASTAR PHARMACEUTICALS
11.9.1 AMPHASTAR PHARMACEUTICALS Company Details
11.9.2 AMPHASTAR PHARMACEUTICALS Business Overview
11.9.3 AMPHASTAR PHARMACEUTICALS Isoprenaline (Isoproterenol) Introduction
11.9.4 AMPHASTAR PHARMACEUTICALS Revenue in Isoprenaline (Isoproterenol) Business (2016-2021)
11.9.5 AMPHASTAR PHARMACEUTICALS Recent Development
11.10 Biophore
11.10.1 Biophore Company Details
11.10.2 Biophore Business Overview
11.10.3 Biophore Isoprenaline (Isoproterenol) Introduction
11.10.4 Biophore Revenue in Isoprenaline (Isoproterenol) Business (2016-2021)
11.10.5 Biophore Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Isoprenaline (Isoproterenol) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Injection
Table 3. Key Players of Tablets
Table 4. Key Players of Others
Table 5. Global Isoprenaline (Isoproterenol) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Isoprenaline (Isoproterenol) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Isoprenaline (Isoproterenol) Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Isoprenaline (Isoproterenol) Market Share by Regions (2016-2021)
Table 9. Global Isoprenaline (Isoproterenol) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Isoprenaline (Isoproterenol) Market Share by Regions (2022-2027)
Table 11. Isoprenaline (Isoproterenol) Market Trends
Table 12. Isoprenaline (Isoproterenol) Market Drivers
Table 13. Isoprenaline (Isoproterenol) Market Challenges
Table 14. Isoprenaline (Isoproterenol) Market Restraints
Table 15. Global Isoprenaline (Isoproterenol) Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Isoprenaline (Isoproterenol) Market Share by Players (2016-2021)
Table 17. Global Top Isoprenaline (Isoproterenol) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Isoprenaline (Isoproterenol) as of 2020)
Table 18. Ranking of Global Top Isoprenaline (Isoproterenol) Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Isoprenaline (Isoproterenol) Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Isoprenaline (Isoproterenol) Product Solution and Service
Table 22. Date of Enter into Isoprenaline (Isoproterenol) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Isoprenaline (Isoproterenol) Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Isoprenaline (Isoproterenol) Revenue Market Share by Type (2016-2021)
Table 26. Global Isoprenaline (Isoproterenol) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Isoprenaline (Isoproterenol) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Isoprenaline (Isoproterenol) Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Isoprenaline (Isoproterenol) Revenue Market Share by Application (2016-2021)
Table 30. Global Isoprenaline (Isoproterenol) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Isoprenaline (Isoproterenol) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Isoprenaline (Isoproterenol) Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Isoprenaline (Isoproterenol) Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Isoprenaline (Isoproterenol) Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Isoprenaline (Isoproterenol) Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Isoprenaline (Isoproterenol) Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Isoprenaline (Isoproterenol) Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Isoprenaline (Isoproterenol) Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Isoprenaline (Isoproterenol) Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Isoprenaline (Isoproterenol) Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Isoprenaline (Isoproterenol) Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Isoprenaline (Isoproterenol) Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Isoprenaline (Isoproterenol) Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Isoprenaline (Isoproterenol) Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Isoprenaline (Isoproterenol) Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Isoprenaline (Isoproterenol) Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Isoprenaline (Isoproterenol) Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Isoprenaline (Isoproterenol) Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Isoprenaline (Isoproterenol) Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Isoprenaline (Isoproterenol) Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Isoprenaline (Isoproterenol) Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Isoprenaline (Isoproterenol) Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Isoprenaline (Isoproterenol) Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Isoprenaline (Isoproterenol) Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Isoprenaline (Isoproterenol) Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Isoprenaline (Isoproterenol) Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Isoprenaline (Isoproterenol) Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Isoprenaline (Isoproterenol) Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Isoprenaline (Isoproterenol) Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Isoprenaline (Isoproterenol) Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Isoprenaline (Isoproterenol) Market Size by Country (2022-2027) & (US$ Million)
Table 62. Sanofi Aventis Company Details
Table 63. Sanofi Aventis Business Overview
Table 64. Sanofi Aventis Isoprenaline (Isoproterenol) Product
Table 65. Sanofi Aventis Revenue in Isoprenaline (Isoproterenol) Business (2016-2021) & (US$ Million)
Table 66. Sanofi Aventis Recent Development
Table 67. HOSPIRA Company Details
Table 68. HOSPIRA Business Overview
Table 69. HOSPIRA Isoprenaline (Isoproterenol) Product
Table 70. HOSPIRA Revenue in Isoprenaline (Isoproterenol) Business (2016-2021) & (US$ Million)
Table 71. HOSPIRA Recent Development
Table 72. NEXUS PHARMAACEUTICALS Company Details
Table 73. NEXUS PHARMAACEUTICALS Business Overview
Table 74. NEXUS PHARMAACEUTICALS Isoprenaline (Isoproterenol) Product
Table 75. NEXUS PHARMAACEUTICALS Revenue in Isoprenaline (Isoproterenol) Business (2016-2021) & (US$ Million)
Table 76. NEXUS PHARMAACEUTICALS Recent Development
Table 77. Amneal Pharmaceuticals, Inc Company Details
Table 78. Amneal Pharmaceuticals, Inc Business Overview
Table 79. Amneal Pharmaceuticals, Inc Isoprenaline (Isoproterenol) Product
Table 80. Amneal Pharmaceuticals, Inc Revenue in Isoprenaline (Isoproterenol) Business (2016-2021) & (US$ Million)
Table 81. Amneal Pharmaceuticals, Inc Recent Development
Table 82. LGM Pharma Company Details
Table 83. LGM Pharma Business Overview
Table 84. LGM Pharma Isoprenaline (Isoproterenol) Product
Table 85. LGM Pharma Revenue in Isoprenaline (Isoproterenol) Business (2016-2021) & (US$ Million)
Table 86. LGM Pharma Recent Development
Table 87. Cipla Company Details
Table 88. Cipla Business Overview
Table 89. Cipla Isoprenaline (Isoproterenol) Product
Table 90. Cipla Revenue in Isoprenaline (Isoproterenol) Business (2016-2021) & (US$ Million)
Table 91. Cipla Recent Development
Table 92. Recipharm AB Company Details
Table 93. Recipharm AB Business Overview
Table 94. Recipharm AB Isoprenaline (Isoproterenol) Product
Table 95. Recipharm AB Revenue in Isoprenaline (Isoproterenol) Business (2016-2021) & (US$ Million)
Table 96. Recipharm AB Recent Development
Table 97. Triveni Interchem Company Details
Table 98. Triveni Interchem Business Overview
Table 99. Triveni Interchem Revenue in Isoprenaline (Isoproterenol) Business (2016-2021) & (US$ Million)
Table 100. Triveni Interchem Recent Development
Table 101. AMPHASTAR PHARMACEUTICALS Company Details
Table 102. AMPHASTAR PHARMACEUTICALS Business Overview
Table 103. AMPHASTAR PHARMACEUTICALS Isoprenaline (Isoproterenol) Product
Table 104. AMPHASTAR PHARMACEUTICALS Revenue in Isoprenaline (Isoproterenol) Business (2016-2021) & (US$ Million)
Table 105. AMPHASTAR PHARMACEUTICALS Recent Development
Table 106. Biophore Company Details
Table 107. Biophore Business Overview
Table 108. Biophore Isoprenaline (Isoproterenol) Product
Table 109. Biophore Revenue in Isoprenaline (Isoproterenol) Business (2016-2021) & (US$ Million)
Table 110. Biophore Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Isoprenaline (Isoproterenol) Market Share by Type: 2020 VS 2027
Figure 2. Injection Features
Figure 3. Tablets Features
Figure 4. Others Features
Figure 5. Global Isoprenaline (Isoproterenol) Market Share by Application: 2020 VS 2027
Figure 6. Bradycardia Case Studies
Figure 7. Asthma Case Studies
Figure 8. Heart Block Case Studies
Figure 9. Others Case Studies
Figure 10. Isoprenaline (Isoproterenol) Report Years Considered
Figure 11. Global Isoprenaline (Isoproterenol) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Isoprenaline (Isoproterenol) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Isoprenaline (Isoproterenol) Market Share by Regions: 2020 VS 2027
Figure 14. Global Isoprenaline (Isoproterenol) Market Share by Regions (2022-2027)
Figure 15. Global Isoprenaline (Isoproterenol) Market Share by Players in 2020
Figure 16. Global Top Isoprenaline (Isoproterenol) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Isoprenaline (Isoproterenol) as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Isoprenaline (Isoproterenol) Revenue in 2020
Figure 18. Global Isoprenaline (Isoproterenol) Revenue Market Share by Type (2016-2021)
Figure 19. Global Isoprenaline (Isoproterenol) Revenue Market Share by Type (2022-2027)
Figure 20. North America Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Isoprenaline (Isoproterenol) Market Share by Type (2016-2027)
Figure 22. North America Isoprenaline (Isoproterenol) Market Share by Application (2016-2027)
Figure 23. North America Isoprenaline (Isoproterenol) Market Share by Country (2016-2027)
Figure 24. United States Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Isoprenaline (Isoproterenol) Market Share by Type (2016-2027)
Figure 28. Europe Isoprenaline (Isoproterenol) Market Share by Application (2016-2027)
Figure 29. Europe Isoprenaline (Isoproterenol) Market Share by Country (2016-2027)
Figure 30. Germany Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Isoprenaline (Isoproterenol) Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Isoprenaline (Isoproterenol) Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Isoprenaline (Isoproterenol) Market Share by Region (2016-2027)
Figure 40. China Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Isoprenaline (Isoproterenol) Market Share by Type (2016-2027)
Figure 48. Latin America Isoprenaline (Isoproterenol) Market Share by Application (2016-2027)
Figure 49. Latin America Isoprenaline (Isoproterenol) Market Share by Country (2016-2027)
Figure 50. Mexico Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Isoprenaline (Isoproterenol) Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Isoprenaline (Isoproterenol) Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Isoprenaline (Isoproterenol) Market Share by Country (2016-2027)
Figure 56. Turkey Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Isoprenaline (Isoproterenol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Sanofi Aventis Revenue Growth Rate in Isoprenaline (Isoproterenol) Business (2016-2021)
Figure 60. HOSPIRA Revenue Growth Rate in Isoprenaline (Isoproterenol) Business (2016-2021)
Figure 61. NEXUS PHARMAACEUTICALS Revenue Growth Rate in Isoprenaline (Isoproterenol) Business (2016-2021)
Figure 62. Amneal Pharmaceuticals, Inc Revenue Growth Rate in Isoprenaline (Isoproterenol) Business (2016-2021)
Figure 63. LGM Pharma Revenue Growth Rate in Isoprenaline (Isoproterenol) Business (2016-2021)
Figure 64. Cipla Revenue Growth Rate in Isoprenaline (Isoproterenol) Business (2016-2021)
Figure 65. Recipharm AB Revenue Growth Rate in Isoprenaline (Isoproterenol) Business (2016-2021)
Figure 66. Triveni Interchem Revenue Growth Rate in Isoprenaline (Isoproterenol) Business (2016-2021)
Figure 67. AMPHASTAR PHARMACEUTICALS Revenue Growth Rate in Isoprenaline (Isoproterenol) Business (2016-2021)
Figure 68. Biophore Revenue Growth Rate in Isoprenaline (Isoproterenol) Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---